SEC Form 4 · accession 0001264931-15-000089
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Pearce
Director
Period of report
Jan 8, 2015
Accepted (ET)
Feb 17, 2015 · 12:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jan 8, 2015 | J | 200,000 | $0.00 | D | 1,876,125 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person did not sell these shares but rather transferred these shares in connection with the settlement and termination of a consulting agreement between the issuer and a consultant under which the issuer owed the consultant certain fees and shares of the issuer's common stock. All of the reporting person's shares of the issuer's common stock are restricted.
Remarks
ORIGINAL FORM 4 NOT TIMELY FILED